RemeGen荣昌生物 is the older company (2013 vs 2008).
Side-by-Side Comparison
| Metric | Ascletis Pharma Inc. | RemeGen荣昌生物 |
|---|---|---|
| Founded | ||
| Founded | 2013 | 2008 older |
| Headquarters | ||
| Headquarters | China | Yantai, China |
| Employees | ||
| Employees | 32 | 35 |
| Industry | ||
| Industry | Health Care, Health and Wellness | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Series B | Post IPO |
| Total Funding | ||
| Total Funding | $255.00M | $1.03B |
| Funding Rounds | ||
| Funding Rounds | 4 | 3 |
| Services | ||
| Services | Not tracked yet | Drug Discovery, Research and Development, Biological Medicine Manufacturing, Clinical Trial Conducting, New Drug Market Launch |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with Major Diseases, Healthcare Providers, Medical Institutions, Pharmaceutical Distributors |
| Taxonomy | ||
| Taxonomy | Biotech, R&D, Innovative Drugs, NASH, Cancer, HIV/AIDS, Viral Hepatitis, Drug Development, Global Market, Clinical Stage, Specialty Therapeutics, Joint Venture, Commercialization, Clinical Proof-of-concept, Global Partnering | Biologics, Biotech Innovation, Therapeutic Innovation, Cancer Treatment, Autoimmune Disease Therapy, Eye Disease Treatment, Biopharmaceutical Industry, ADC (Antibody-Drug Conjugates), Biological Drugs, Clinical Studies, Drug Development, Unmet Clinical Needs, Global Commercialization, Scientific Research Investment, Differentiated Drugs |
| Website | ||
| Website | ascletis.com | remegen.cn |
About Ascletis Pharma Inc.
Ascletis Pharma Inc. is an innovative R&D driven biotech company listed on the Hong Kong Stock Exchange (1672.HK). It is dedicated to developing and commercializing innovative drugs in the areas of NASH, cancer lipid metabolism, oral checkpoint inhibitors, viral hepatitis, and HIV/AIDS for unmet med...
About RemeGen荣昌生物
RemeGen荣昌生物 is positioning itself as a trailblazer in the biotech industry with its innovative approach to biologic medicines. Founded in 2008, this Chinese biotech firm is focused on transforming the treatment landscape for cancer, autoimmune, and eye diseases by pioneering biologics. With a mi...
We will tell you when either one moves
BounceWatch watches Ascletis Pharma Inc. and RemeGen荣昌生物 for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Ascletis Pharma Inc. and RemeGen荣昌生物 — by email.
Frequently Asked Questions
Compare Ascletis Pharma Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Ascletis Pharma Inc. on 14 Sep 2024, and RemeGen荣昌生物 on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.